Moradi A, Khodabakhshi B, Sadeghipour M, Besharat S, Tabarraei A
Infectious Diseases Research Centre, Golestan University of Medical Sciences, Golestan Research Center of Gastroenterology and Hepatology, Gorgan City, Golestan Province, Iran.
Trop Doct. 2011 Jul;41(3):129-31. doi: 10.1258/td.2011.100418. Epub 2011 Apr 30.
Co-infection of HBV, HCV and HIV is common because of shared routes of viral transmission with increased risk of morbidity and mortality. Anti-HCV and HIV antibodies of 168 HBV patients were assayed. Co-infection of HCV in HBV patients was seen in four cases (2.4%). Simultaneous infection of HIV in HBV patents was seen in three cases (1.8%). There was no simultaneous co-infection of HCV, HIV and HBV. It is recommended that all patients are screened for possible co-infections before initiating treatment.
由于病毒传播途径相同，乙肝病毒（HBV）、丙肝病毒（HCV）和艾滋病毒（HIV）合并感染很常见，发病和死亡风险增加。对168例乙肝患者的丙肝和艾滋病毒抗体进行了检测。在乙肝患者中发现4例（2.4%）合并丙肝感染。在乙肝患者中发现3例（1.8%）同时感染艾滋病毒。未发现丙肝、艾滋病毒和乙肝同时合并感染的情况。建议在开始治疗前对所有患者进行可能合并感染的筛查。
